Corporate Gorvernance
Overview
The Medicines Regulatory Board, established under Section 6 of the Medicines and Related Substances Act (MRSA), serves as BoMRA’s governing body and has established a governance framework to ensure compliance with best practices and optimise its function in supporting BoMRA’s achievement of its mandate.
This Governance framework is built on three key pillars:
- The Medicines and Related Substances Act (MRSA)
- Governance requirements for statutory bodies, including those set by the Public Enterprises Evaluation and Privatisation Agency (PEEPA) and the Botswana Accountancy Oversight Authority (BAOA)
- Voluntary adoption of the King IV Corporate Governance Code. This robust framework ensures that BoMRA complies with legal requirements while adhering to international best practices in corporate governance.
Overview
The Medicines Regulatory Board, established under Section 6 of the Medicines and Related Substances Act (MRSA), serves as BoMRA’s governing body and has established a governance framework to ensure compliance with best practices and optimise its function in supporting BoMRA’s achievement of its mandate.
This Governance framework is built on three key pillars:
- 1. The Medicines and Related Substances Act (MRSA)
- 2. Governance requirements for statutory bodies, including those set by the Public Enterprises Evaluation and Privatisation Agency (PEEPA) and the Botswana
- 3. Voluntary adoption of the King IV Corporate Governance Code. This robust framework ensures that BoMRA complies with legal requirements while adhering to international best practices in corporate governance.